pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

23,715 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×clear all
type
  • approval18,987
  • phase readout7,208
  • device 510k5,000
  • grant4,728
  • 8k filing3,603
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings585
  • therapy area

    no tagged catalysts yet

    Week of Feb 23, 2026

    17
    ›Mar 1, 2026grant183d agoUNIVERSITY OF WASHINGTON — Applying novel imaging and transcriptomics to mechanisms of cirrhosis- relate...University of Washington

    DK grant. $192,763. PI: Michael Louis Granda

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoPENNSYLVANIA STATE UNIV HERSHEY MED CTR — Mechanisms of the inflammatory activation of mesenchymal cells in ulcerative ...

    DK grant. $708,697. PI: Iryna V Pinchuk

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoDARTMOUTH COLLEGE — Mechanisms of SWI/SNF complex chromatin targeting selectivity

    GM grant. $1,317,220. PI: Xiaofeng Wang

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoYALE UNIVERSITY — Characterizing genetic effects on molecular phenotypes at the single-cell res...

    DA grant. $2,263,424. PI: Mark Bender Gerstein

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoUNIVERSITY OF MIAMI SCHOOL OF MEDICINE — STRIVES: Status-neutral tele-health concierge intervention for people who use...

    DA grant. $793,508. PI: Tyler Scott Bartholomew

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoEMORY UNIVERSITY — Neuromelanin Formation and Toxicity in the Locus Coeruleus: The Role of Norep...Emory University

    AG grant. $50,114. PI: Leslie Hassanein

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Metabolomic correlates of improved Alzheimer’s disease polygenic risk score f...

    AG grant. $41,757. PI: Emily Drzymalla

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoWEILL MEDICAL COLL OF CORNELL UNIV — Structural determination of TrkB assembly and activation

    GM grant. $76,300. PI: PAMELA GALLO

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoMASSACHUSETTS GENERAL HOSPITAL — Planning for Prevention of Parkinson's Disease and Related Synucleinopathies:...Massachusetts General Hospital

    NS grant. $15,000. PI: MICHAEL A SCHWARZSCHILD

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoHARVARD MEDICAL SCHOOL — Molecular mechanisms regulating ciliary motility

    GM grant. $647,706. PI: Alan Brown

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoOHIO STATE UNIVERSITY — Genomics-Accelerated Discovery and Biosynthesis of Phosphonic Acid Natural Pr...

    GM grant. $410,893. PI: Kou-San Ju

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoVIRGINIA POLYTECHNIC INST AND ST UNIV — Specialized adaptations in the model alpha-proteobacterium Sinorhizobium meli...

    GM grant. $422,314. PI: Birgit E Scharf

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoOREGON STATE UNIVERSITY — New ionization source technology for single-cell multi-omics

    GM grant. $408,375. PI: CLAUDIA S MAIER

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Molecular Regulators of Mitochondrial Dynamics in the Progression of Secondar...

    NS grant. $43,714. PI: Reagan Leann Speas

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoGEORGE WASHINGTON UNIVERSITY — Investigating nerve fiber-associated macrophages in prostate development

    DK grant. $43,714. PI: Sally Feng

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoUNIVERSITY OF PENNSYLVANIA — Mechanistic Insights into IP3R1 role in Synaptic Function and DiseaseUniversity of Pennsylvania

    NS grant. $49,538. PI: Eve Gautreaux

    full page →nih reporter ↗
    ›Mar 1, 2026grant183d agoUNIVERSITY OF CALIFORNIA BERKELEY — Molecular insights into regulator-dependent transcription initiation pathways

    GM grant. $75,520. PI: Nicholas Zuo-Bing Lue

    full page →nih reporter ↗

    Week of Mar 2, 2026

    33
    ›Mar 2, 2026approval182d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

    Sponsor: INNOGENIX. Form: TABLET. Route: ORAL

    full page →METRONIDAZOLE →fda approvals ↗
    ›Mar 2, 2026approval
    ← prev
    page 442 of 475
    next →
    182d ago
    ONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →ondansetron hydrochloride CR →fda approvals ↗
    ›Mar 2, 2026approval182d agoVENOFER (IRON SUCROSE) — FDA approvalInternational Medication Systems Ltd

    Sponsor: AM REGENT. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Mar 2, 2026approval182d agoIMODIUM MULTI-SYMPTOM RELIEF (LOPERAMIDE HYDROCHLORIDE) — FDA approvalBionpharma Inc

    Sponsor: KENVUE BRANDS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 2, 2026approval182d agoOXCARBAZEPINE — FDA approvalOXCARBAZEPINE

    Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL

    full page →OXCARBAZEPINE →fda approvals ↗
    ›Mar 2, 2026approval182d agoRIVAROXABAN — FDA approvalRIVAROXABAN

    Sponsor: APOTEX. Form: FOR SUSPENSION. Route: ORAL

    full page →RIVAROXABAN →fda approvals ↗
    ›Mar 2, 2026approval182d agoBOSULIF (BOSUTINIB MONOHYDRATE) — FDA approvalAlembic Pharmaceuticals Inc

    Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 2, 2026approval182d agoSODIUM ACETATE — FDA approvalSODIUM ACETATE

    Sponsor: AMNEAL. Form: SOLUTION. Route: INTRAVENOUS

    full page →SODIUM ACETATE →fda approvals ↗
    ›Mar 2, 2026approval182d agoMOXIFLOXACIN HYDROCHLORIDE — FDA approvalMOXIFLOXACIN HYDROCHLORIDE

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →MOXIFLOXACIN HYDROCHLORIDE →fda approvals ↗
    ›Mar 2, 2026approval182d agoBOSULIF (BOSUTINIB MONOHYDRATE) — FDA approvalAlembic Pharmaceuticals Inc

    Sponsor: PF PRISM CV. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 2, 2026grant182d agoTEXAS A&M AGRILIFE RESEARCH — NAMs-Decisions Center: New Approach Methods for Decisions on Industrial and C...

    TR grant. $3,124,604. PI: Ivan Rusyn

    full page →nih reporter ↗
    ›Mar 2, 2026grant182d agoOREGON HEALTH & SCIENCE UNIVERSITY — Optimizing cAMP and PKA sensors for cell-specific dissection of neuronal circ...

    MH grant. $2,039,804. PI: Isabelle Rhyssa Joe Eduria Baconguis

    full page →nih reporter ↗
    ›Mar 2, 2026grant182d agoUNIVERSITY OF PENNSYLVANIA — Harnessing XNAs to Expand the Genetic Toolkit for RNA Silencing and RNA editingUniversity of Pennsylvania

    GM grant. $406,250. PI: LIJUN ZHOU

    full page →nih reporter ↗
    ›Mar 2, 2026grant182d agoNORTHEASTERN UNIVERSITY — Integrated mass spectrometry strategies to decipher metabolite-protein cross ...

    GM grant. $434,000. PI: Owen Samuel Skinner

    full page →nih reporter ↗
    ›Mar 2, 2026grant182d agoUNIVERSITY OF COLORADO DENVER — Classification of Disease Associated B Cell Receptors in Multiple SclerosisUniversity of Colorado Denver

    NS grant. $427,712. PI: WENDY B MACKLIN

    full page →nih reporter ↗
    ›Mar 2, 2026grant182d agoIOWA STATE UNIVERSITY — Transcriptome- and proteome-wide effects of circular RNAs of SMA genes

    NS grant. $420,750. PI: RAVINDRA N SINGH

    full page →nih reporter ↗
    ›Mar 2, 2026grant182d agoUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH — Development and Application of Nicotinic Acetylcholine Receptor Targeted Pept...University of Utah

    GM grant. $500,500. PI: J MICHAEL MCINTOSH

    full page →nih reporter ↗
    ›Mar 2, 2026grant182d agoNEW YORK UNIVERSITY — Replay-Driven Task Orthogonalization and Abstraction for Continual LearningNew York University

    MH grant. $75,052. PI: Zhenglong Zhou

    full page →nih reporter ↗
    ›Mar 3, 2026approval181d agoBOSENTAN — FDA approvalBOSENTAN

    Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL

    full page →BOSENTAN →fda approvals ↗
    ›Mar 3, 2026approval181d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval181d agoBOSENTAN — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

    Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval181d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval181d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval181d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval181d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval181d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval181d agoBOSENTAN — FDA approvalBOSENTAN

    Sponsor: NATCO PHARMA LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →BOSENTAN →fda approvals ↗
    ›Mar 3, 2026approval181d agoBOSENTAN — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS CO. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval181d agoBOSENTAN — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

    Sponsor: PH HEALTH. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval181d agoFLUTICASONE PROPIONATE — FDA approvalFougera Pharmaceuticals Inc

    Sponsor: GLENMARK SPECLT. Form: AEROSOL, METERED. Route: INHALATION

    full page →fda approvals ↗
    ›Mar 3, 2026approval181d agoTRACLEER (BOSENTAN) — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

    Sponsor: ACTELION. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval181d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval181d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    $NSRX2.7000-1.82%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%